Ksolves India Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
Ksolves India has a total shareholder equity of ₹322.9M and total debt of ₹0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₹567.8M and ₹244.9M respectively. Ksolves India's EBIT is ₹491.0M making its interest coverage ratio -259.1. It has cash and short-term investments of ₹155.9M.
Anahtar bilgiler
0%
Borç/özkaynak oranı
₹0
Borç
Faiz karşılama oranı | -259.1x |
Nakit | ₹155.88m |
Eşitlik | ₹322.94m |
Toplam yükümlülükler | ₹244.89m |
Toplam varlıklar | ₹567.82m |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Ksolves India's (NSE:KSOLVES) Dividend Will Be ₹8.00
Oct 21We Think You Should Be Aware Of Some Concerning Factors In Ksolves India's (NSE:KSOLVES) Earnings
May 10Investors Interested In Ksolves India Limited's (NSE:KSOLVES) Earnings
May 04Here's Why We Think Ksolves India (NSE:KSOLVES) Is Well Worth Watching
Dec 23We Ran A Stock Scan For Earnings Growth And Ksolves India (NSE:KSOLVES) Passed With Ease
Jul 11Ksolves India Limited's (NSE:KSOLVES) 27% Jump Shows Its Popularity With Investors
Apr 19Here's Why Ksolves India (NSE:KSOLVES) Has Caught The Eye Of Investors
Oct 19Here's Why We Think Ksolves India (NSE:KSOLVES) Might Deserve Your Attention Today
Jun 29Does Ksolves India (NSE:KSOLVES) Deserve A Spot On Your Watchlist?
Jul 21Ksolves India (NSE:KSOLVES) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
May 04Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: KSOLVES's short term assets (₹508.0M) exceed its short term liabilities (₹209.4M).
Uzun Vadeli Yükümlülükler: KSOLVES's short term assets (₹508.0M) exceed its long term liabilities (₹35.5M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: KSOLVES is debt free.
Borcun Azaltılması: KSOLVES had no debt 5 years ago.
Borç Kapsamı: KSOLVES has no debt, therefore it does not need to be covered by operating cash flow.
Faiz Kapsamı: KSOLVES has no debt, therefore coverage of interest payments is not a concern.